MVI, Sanaria explore new approaches to malaria vaccine

11/4/2009 | Thaindian News

The PATH Malaria Vaccine Initiative has teamed up with Sanaria to develop an experimental malaria vaccine that will use a weakened form of the Plasmodium falciparum parasite. The vaccine currently is in human trials in the U.S. Other vaccine approaches being considered by the researchers include preventing the transmission of the disease from mosquitoes to humans.

View Full Article in:

Thaindian News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC